1. Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation. Brophy ML, Dong Y, Tao H, Yancey PG, Song K, Zhang K, Wen A, Wu H, Lee Y, Malovichko MV, Sithu SD, Wong S, Yu L, Kocher O, Bischoff J, Srivastava S, Linton MF, Ley K, Chen H (2019) Circ Res 124(4): e6-e19
    › Primary publication · 30595089 (PubMed) · PMC6375743 (PubMed Central)
  2. Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice. Babaev VR, Ding L, Zhang Y, May JM, Ramsey SA, Vickers KC, Linton MF (2019) Arterioscler Thromb Vasc Biol 39(2): 156-169
    › Primary publication · 30567482 (PubMed) · PMC6344270 (PubMed Central)
  3. Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis. Wiese CB, Zhong J, Xu ZQ, Zhang Y, Ramirez Solano MA, Zhu W, Linton MF, Sheng Q, Kon V, Vickers KC (2019) Atherosclerosis : 121-131
    › Primary publication · 30731284 (PubMed)
  4. Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretion. Sedgeman LR, Beysen C, Ramirez Solano MA, Michell DL, Sheng Q, Zhao S, Turner S, Linton MF, Vickers KC (2019) Sci Rep 9(1): 3803
    › Primary publication · 30846744 (PubMed) · PMC6405899 (PubMed Central)
  5. Association Between Low-Density Lipoprotein Cholesterol Levels and Risk for Sepsis Among Patients Admitted to the Hospital With Infection. Feng Q, Wei WQ, Chaugai S, Leon BGC, Mosley JD, Leon DAC, Jiang L, Ihegword A, Shaffer CM, Linton MF, Chung CP, Stein CM (2019) JAMA Netw Open 2(1): e187223
    › Primary publication · 30657536 (PubMed) · PMC6447031 (PubMed Central)
  6. Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor Mice Improves Indices of Cardiometabolic Disease. May-Zhang LS, Chen Z, Dosoky NS, Yancey PG, Boyd KL, Hasty AH, Linton MF, Davies SS (2019) Sci Rep 9(1): 420
    › Primary publication · 30674978 (PubMed) · PMC6344515 (PubMed Central)
  7. Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records. Feng Q, Wei WQ, Chung CP, Levinson RT, Sundermann AC, Mosley JD, Bastarache L, Ferguson JF, Cox NJ, Roden DM, Denny JC, Linton MF, Edwards DRV, Stein CM (2018) PLoS Med 15(8): e1002642
    › Primary publication · 30153257 (PubMed) · PMC6112635 (PubMed Central)
  8. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function. May-Zhang LS, Yermalitsky V, Huang J, Pleasent T, Borja MS, Oda MN, Jerome WG, Yancey PG, Linton MF, Davies SS (2018) J Biol Chem 293(24): 9176-9187
    › Primary publication · 29712723 (PubMed) · PMC6005447 (PubMed Central)
  9. Loss of in Monocyte/Macrophages Suppresses Their Proliferation and Viability Reducing Atherosclerosis in LDLR Null Mice. Babaev VR, Huang J, Ding L, Zhang Y, May JM, Linton MF (2018) Front Immunol : 215
    › Primary publication · 29487597 (PubMed) · PMC5816794 (PubMed Central)
  10. Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding. Zhu L, Shi J, Luu TN, Neuman JC, Trefts E, Yu S, Palmisano BT, Wasserman DH, Linton MF, Stafford JM (2018) Mol Metab : 106-116
    › Primary publication · 29331506 (PubMed) · PMC5985047 (PubMed Central)